Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2482
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era ; volume:17 ; number:1 ; day:10 ; month:5 ; year:2017 ; pages:1-8 ; date:12.2017
BMC surgery ; 17, Heft 1 (10.5.2017), 1-8, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Yokoyama, Shintaro
- Beteiligte Personen und Organisationen
-
Mitsuoka, Masahiro
Kinugasa, Tetsushi
Hashiguchi, Toshihiro
Matsumoto, Ryoichi
Murakami, Daigo
Nishi, Tatsuya
Yoshiyama, Koichi
Kashihara, Masaki
Takamori, Shinzo
Akagi, Yoshito
SpringerLink (Online service)
- DOI
-
10.1186/s12893-017-0252-8
- URN
-
urn:nbn:de:1111-201705204969
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yokoyama, Shintaro
- Mitsuoka, Masahiro
- Kinugasa, Tetsushi
- Hashiguchi, Toshihiro
- Matsumoto, Ryoichi
- Murakami, Daigo
- Nishi, Tatsuya
- Yoshiyama, Koichi
- Kashihara, Masaki
- Takamori, Shinzo
- Akagi, Yoshito
- SpringerLink (Online service)
Ähnliche Objekte (12)
The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
Radioembolization for Metastatic Colorectal Cancer
Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape
Genetic markers for clinical outcome of chemotherapeutic treatment in colorectal cancer patients
Colorectal Cancer with Uncommon Metastatic Spread
USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer
Second primary colorectal cancer after the initial primary colorectal cancer
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
Intra-Arterial Therapies for Metastatic Colorectal Cancer
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
Distribution of Metastatic Cancer Cells in Colorectal Mesentery
The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
Radioembolization for Metastatic Colorectal Cancer
Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape
Genetic markers for clinical outcome of chemotherapeutic treatment in colorectal cancer patients
Colorectal Cancer with Uncommon Metastatic Spread
USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer
Second primary colorectal cancer after the initial primary colorectal cancer
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
Intra-Arterial Therapies for Metastatic Colorectal Cancer
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
Distribution of Metastatic Cancer Cells in Colorectal Mesentery
The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
Chemotherapeutic treatment of colorectal cancer in pregnancy: case report
Radioembolization for Metastatic Colorectal Cancer
Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape
Genetic markers for clinical outcome of chemotherapeutic treatment in colorectal cancer patients
Colorectal Cancer with Uncommon Metastatic Spread
USP35 promotes cell proliferation and chemotherapeutic resistance through stabilizing FUCA1 in colorectal cancer
Second primary colorectal cancer after the initial primary colorectal cancer
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
Intra-Arterial Therapies for Metastatic Colorectal Cancer
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer